5/500 4221 (Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg)
Generic Name: metformin/saxagliptin
Pill imprint 5/500 4221 has been identified as Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg.
Kombiglyze XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 5/500 4221
- metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
- Inactive Ingredients:
- carboxymethylcellulose sodium
hypromellose 2208 (15000 mPa.s)
hypromellose 2910 (15 mPa.s)
|NDC Code||Manufacturer / Repackager|
|00310-6135||AstraZeneca Pharmaceuticals LP|
Note: Inactive ingredients may vary.
More about Kombiglyze XR (metformin / saxagliptin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.